In conclusion, we identified ten methylation markers affecting four genes (SMOC1, KCNA4, SLC25A21, and UPP1) that are associated with glioma grade progression, and demonstrate a strong prognostic probability for patient prognosis which is also able to identify patients usually considered to be good survivors (oligodendroglioma). This evidence concerns the gene SMOC1 and central nervous system cancer.